Howard Horn
Director of Finance/CFO at ULTRAGENYX PHARMACEUTICAL INC.
Net worth: 6 M $ as of 29/04/2024
Network origin in Howard Horn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
71
| Public Company | Pharmaceuticals: Major | 71 |
| Public Company | Biotechnology | 29 | |
| Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Howard Horn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Compliance Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Masters Business Admin | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor | |
| DIMENSION THERAPEUTICS INC | Biotechnology | President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Operating Officer Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Founder Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member General Counsel Compliance Officer | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Purdue University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| BLACKSTONE INC. | Investment Managers | Consultant / Advisor Private Equity Analyst | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| PRIME MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| GILEAD SCIENCES, INC. | Biotechnology | General Counsel Investor Relations Contact | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Georgetown University | College/University | Director/Board Member Doctorate Degree |
Statistics
International
| United States | 47 |
| China | 2 |
| Ireland | 2 |
| United Kingdom | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 8 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 370 |
| Corporate Officer/Principal | 220 |
| Independent Dir/Board Member | 133 |
| Undergraduate Degree | 82 |
| Chief Tech/Sci/R&D Officer | 67 |
Most connected contacts
| Insiders | |
|---|---|
| Kristina Burow | 40 |
| William Young | 32 |
| Dipchand Nishar | 31 |
| Steven Holtzman | 28 |
| Adam Koppel | 26 |
| Douglas Williams | 25 |
| Daniel Welch | 24 |
| Charles Sigal | 20 |
| Sona Saira Ramasastry | 19 |
| Timothy Harris | 19 |
| Deborah Dunsire | 19 |
| Jeffrey Hatfield | 18 |
| Glenn F. Pierce | 17 |
| Matthew Fust | 16 |
| Adriana Karaboutis | 16 |
- Stock Market
- Insiders
- Howard Horn
- Company connections
